Overview
Bayer Innovation GmbH
Bayer Links
Investor Relations
About Bayer Innovation
The Bayer Innovation GmbH
BAYER INNOVATION GmbH (BIG) is part of Bayer’s innovation strategy and complements the innovation activities of the different subgroups in the fields of health care, nutrition and high-quality materials.
Objective of BIG is to identify and develop new growth opportunities, thus preparing entry into new and expanding markets. The fields of activity match Bayer’s overall concept “science for a better life” and take advantage of competences within the subgroups, often in cooperation with external partners such as universities, institutes, start ups or other companies.
Development of innovative solutions across the lines of Bayer’s subgroups and creation of new products and business opportunities are among the strong points of BIG. Currently the focus is on medical technology and the production of plant-made pharmaceuticals.
This way Bayer gains access to attractive future markets. Once these concepts are fully developed they will be committed to commercial integration to appropriate Bayer subgroups, opening up BIG’s resources for new challenges.
Development of innovative solutions across the lines of Bayer’s subgroups and creation of new products and business opportunities are among the strong points of BIG. Currently the focus is on medical technology and the production of plant-made pharmaceuticals.
This way Bayer gains access to attractive future markets. Once these concepts are fully developed they will be committed to commercial integration to appropriate Bayer subgroups, opening up BIG’s resources for new challenges.
Bookmark this page
E-mail this page
Advanced Search
